ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017
Common
Open access · bronzeAbstract readMulticenter Study
In one paragraph
Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
- Genetic Ancestry and Lung Cancer in Latin American Patients: A Crucial Step for Understanding a Diverse Population.Clinical lung cancer · 2025Review
- Single nucleotide variants in lung cancer.Chinese medical journal pulmonary and critical care medicine · 2024Review
- Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population.OncoTargets and therapy · 2023Article
- Potential therapeutic targets shared between leishmaniasis and cancer.Parasitology · 2021Review
- Association of PTEN Gene SNPs rs2299939 With PFS in Patients With Small Cell Lung Cancer Treated With Early Radiotherapy.Frontiers in genetics · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 1 institution in 1 country.
Pawadee LohavanichbutrDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Lori C SakodaDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Christopher I AmosDepartment of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
Susanne M ArnoldDivision of Medical Oncology, University of Kentucky Markey Cancer Center, Lexington, Kentucky.
David C ChristianiDepartment of Environmental Health, Harvard School of Public Health, Boston, Massachusetts.
Michael P A DaviesRoy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
John K FieldRoy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
Eric B HauraDepartment of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
Rayjean J HungLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Takashi KohnoDivision of Genome Biology, National Cancer Research Institute, Tokyo, Japan.
Maria Teresa LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Geoffrey LiuDepartment of Medical Oncology, Princess Margaret Cancer Center and University Health Network, University of Toronto, Toronto, Ontario, Canada.
Yi LiuDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Michael W MarcusRoy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
Grainne M O'KaneDepartment of Medical Oncology, Princess Margaret Cancer Center and University Health Network, University of Toronto, Toronto, Ontario, Canada.
Matthew B SchabathDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
Kouya ShiraishiDivision of Genome Biology, National Cancer Research Institute, Tokyo, Japan.
Stacey A SloneBiostatistics and Bioinformatics Shared Resource Facility, University of Kentucky Markey Cancer Center, Lexington, Kentucky.
Adonina TardónCIBER Epidemiology and Public Health (CIBER-ESP), Health Research Institute Carlos III, Madrid, Spain.
Ping YangDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Kazushi YoshidaDivision of Genome Biology, National Cancer Research Institute, Tokyo, Japan.
Ruyang ZhangDepartment of Environmental Health, Harvard School of Public Health, Boston, Massachusetts.
Xuchen ZongLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Gary E GoodmanDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Noel S WeissDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Chu ChenDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. cchen@fredhutch.org.
Kaiser Permanente · US
Funding
TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5MTranslational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3MTranslational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI SUSAN A KORRICK · 1985 to 2026
$44.6MUniversity of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3MKentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3MTHE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)U01CA063673 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GOODMAN, GARY E · 1994 to 2006
$13.0MSPORE in Lung CancerP50CA119997 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GABRILOVICH, DMITRY I · 2008 to 2012
$11.0MStatistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9MTransdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9MMolecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9MGENETIC SUSCEPTIBILITY TO LUNG CANCERR01CA074386 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 1997 to 2008
$4.8MALPHA 1 AD CARRIERS AND LUNG CANCER RISKR01CA080127 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2000 to 2009
$4.4MNCATS NIH HHS UL1 TR000117NCI NIH HHS K07 CA188142NCI NIH HHS P30 CA023108NCI NIH HHS P30 CA076292NCI NIH HHS P30 CA177558NCI NIH HHS P50 CA119997NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA080127NCI NIH HHS R01 CA084354NCI NIH HHS R01 CA092824NCI NIH HHS R01 CA111703NCI NIH HHS R03 CA077118NCI NIH HHS R35 CA197449NCI NIH HHS U01 CA063673NCI NIH HHS U19 CA148127NCI NIH HHS UM1 CA167462NHLBI NIH HHS R01 HL107612NIEHS NIH HHS P30 ES000002
Abstract
PubMed holds no abstract for this paper.
Indexed as
Genetic Predisposition to DiseaseAdultAgedAged, 80 and overAllelesBiomarkers, TumorDNA RepairFemaleGenotypeHomozygoteHumansKaplan-Meier EstimateMaleMiddle AgedPhosphoric Diester HydrolasesPolymorphism, Single NucleotideBiomarkers, TumorPhosphoric Diester HydrolasesTDP1 protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.